Primer: genomic and proteomic tools for the molecular dissection of disease

Erin Walker, Katherine Siminovitch

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Completion of the Human Genome Project has been rapidly followed by the emergence of high-throughput technologies that combine automation, miniaturization, and many other strategies and tools to enable systematic surveys of genome composition and gene expression. Of particular relevance to the prevention and management of disease are technologies such as high-throughput DNA genotyping, microarray-based gene-expression profiling, and mass spectrometry-facilitated protein profiling—platforms that collectively support the comprehensive analysis of DNA sequence variants across the genome and the global gene and protein expression changes that distinguish health from disease. Now used extensively in all facets of biomedical investigation, genomic and proteomic tools are already beginning to pinpoint molecular variants that influence risk and outcome in common diseases, and to thereby inform and direct development of novel molecular biomarkers and drug targets. As evidenced by recent advances in DNA sequencing methods, continued improvements in the scope, power, and cost efficiency of genomic and proteomic technologies should ensure their capacity to provide the scale and depth of knowledge required for translating genome sequence information into major medical impact.
Original languageEnglish
Pages (from-to)580-589
Number of pages10
JournalNature Clinical Practice Rheumatology
Volume3
Issue number10
DOIs
Publication statusPublished - 2007
Externally publishedYes

Fingerprint

Proteomics
Dissection
Genome
Technology
DNA Sequence Analysis
Human Genome Project
Miniaturization
Gene Expression
Automation
Gene Expression Profiling
Disease Management
Oligonucleotide Array Sequence Analysis
Mass Spectrometry
Proteins
Biomarkers
Costs and Cost Analysis
Health
Pharmaceutical Preparations
Surveys and Questionnaires

Cite this

Walker, Erin ; Siminovitch, Katherine. / Primer: genomic and proteomic tools for the molecular dissection of disease. In: Nature Clinical Practice Rheumatology. 2007 ; Vol. 3, No. 10. pp. 580-589.
@article{71f9eaef21c8464dba3ba433e398d38b,
title = "Primer: genomic and proteomic tools for the molecular dissection of disease",
abstract = "Completion of the Human Genome Project has been rapidly followed by the emergence of high-throughput technologies that combine automation, miniaturization, and many other strategies and tools to enable systematic surveys of genome composition and gene expression. Of particular relevance to the prevention and management of disease are technologies such as high-throughput DNA genotyping, microarray-based gene-expression profiling, and mass spectrometry-facilitated protein profiling—platforms that collectively support the comprehensive analysis of DNA sequence variants across the genome and the global gene and protein expression changes that distinguish health from disease. Now used extensively in all facets of biomedical investigation, genomic and proteomic tools are already beginning to pinpoint molecular variants that influence risk and outcome in common diseases, and to thereby inform and direct development of novel molecular biomarkers and drug targets. As evidenced by recent advances in DNA sequencing methods, continued improvements in the scope, power, and cost efficiency of genomic and proteomic technologies should ensure their capacity to provide the scale and depth of knowledge required for translating genome sequence information into major medical impact.",
author = "Erin Walker and Katherine Siminovitch",
year = "2007",
doi = "10.1038/ncprheum0595",
language = "English",
volume = "3",
pages = "580--589",
journal = "Nature reviews. Rheumatology",
issn = "1745-8382",
publisher = "Nature Publishing Group",
number = "10",

}

Primer: genomic and proteomic tools for the molecular dissection of disease. / Walker, Erin; Siminovitch, Katherine.

In: Nature Clinical Practice Rheumatology, Vol. 3, No. 10, 2007, p. 580-589.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Primer: genomic and proteomic tools for the molecular dissection of disease

AU - Walker, Erin

AU - Siminovitch, Katherine

PY - 2007

Y1 - 2007

N2 - Completion of the Human Genome Project has been rapidly followed by the emergence of high-throughput technologies that combine automation, miniaturization, and many other strategies and tools to enable systematic surveys of genome composition and gene expression. Of particular relevance to the prevention and management of disease are technologies such as high-throughput DNA genotyping, microarray-based gene-expression profiling, and mass spectrometry-facilitated protein profiling—platforms that collectively support the comprehensive analysis of DNA sequence variants across the genome and the global gene and protein expression changes that distinguish health from disease. Now used extensively in all facets of biomedical investigation, genomic and proteomic tools are already beginning to pinpoint molecular variants that influence risk and outcome in common diseases, and to thereby inform and direct development of novel molecular biomarkers and drug targets. As evidenced by recent advances in DNA sequencing methods, continued improvements in the scope, power, and cost efficiency of genomic and proteomic technologies should ensure their capacity to provide the scale and depth of knowledge required for translating genome sequence information into major medical impact.

AB - Completion of the Human Genome Project has been rapidly followed by the emergence of high-throughput technologies that combine automation, miniaturization, and many other strategies and tools to enable systematic surveys of genome composition and gene expression. Of particular relevance to the prevention and management of disease are technologies such as high-throughput DNA genotyping, microarray-based gene-expression profiling, and mass spectrometry-facilitated protein profiling—platforms that collectively support the comprehensive analysis of DNA sequence variants across the genome and the global gene and protein expression changes that distinguish health from disease. Now used extensively in all facets of biomedical investigation, genomic and proteomic tools are already beginning to pinpoint molecular variants that influence risk and outcome in common diseases, and to thereby inform and direct development of novel molecular biomarkers and drug targets. As evidenced by recent advances in DNA sequencing methods, continued improvements in the scope, power, and cost efficiency of genomic and proteomic technologies should ensure their capacity to provide the scale and depth of knowledge required for translating genome sequence information into major medical impact.

U2 - 10.1038/ncprheum0595

DO - 10.1038/ncprheum0595

M3 - Article

VL - 3

SP - 580

EP - 589

JO - Nature reviews. Rheumatology

JF - Nature reviews. Rheumatology

SN - 1745-8382

IS - 10

ER -